Financing co-led by Novo Holdings and the Ljungström family office, with participation from the originator Helsinn, existing ...

"Every day passes by in front of me at breakneck speed.""Before I know it, I'm chased by tasks all day, and at night, I just collapse into bed, completely exhausted."Work, housework, childcare, ...

Dr. Vnuk brings substantial business and corporate development leadership experience from Sanofi, Blackstone, and Pfizer ...

ZYUS Reports Trichomylin Shows Efficacy Signals In Cancer Pain Trial October 01, 2026 10:51 ET ZYUS Life Sciences (ZYUS.V) reported positive Phase 2a UTOPIA-1 data for Trichomylin in cancer pain. The ...

Phase 2 data in adults with atopic dermatitis showed that all three zumilokibart dose regimens met the primary endpoint, with significantly ...

BOSTON, Sept. 20, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma (Nasdaq: CUE), a clinical-stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, today announced ...

What you will learn in this article The details of a famous experiment claiming that "rainy days lower even life satisfaction ...

Wave Life Sciences Ltd. announced the appointment of Monika Vnuk, MD, as Chief Business Officer. Dr. Vnuk brings substantial business and corporate development leadership experience from Sanofi, ...

Cue Biopharma announced positive Phase 2 trial results for CUE-221 in chronic spontaneous urticaria, demonstrating significant efficacy and safety. Cue Biopharma announced positive results from a ...

Clarus Trust increases stake in RPG Life Sciences to 7.04% via open market purchase. Details on shareholding changes and ...

For women who carry pathogenic variants in the BRCA1 or BRCA2 genes, one of the most consequential decisions in preventive ...

Every day, we all make hundreds of decisions and choices: whether to start or complete a task, to speak or respond, to pause ...